Skip to content

Probucol

Lorelco (probucol) is a small molecule pharmaceutical. Probucol was first approved as Lorelco on 1982-01-01. It is used to treat coronary artery disease, hypercholesterolemia, and hyperlipoproteinemias in the USA. The pharmaceutical is active against phospholipid-transporting ATPase ABCA1.
Trade Name Lorelco
Common Name Probucol
Indication coronary artery disease, hypercholesterolemia, hyperlipoproteinemias
Drug Class
Probucol
Get full access now